rofecoxib has been researched along with Peritonitis in 1 studies
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This effect was prevented by rofecoxib treatment indicating the sensitivity of the model for pelvic pain related to peritonitis." | 3.80 | Use of dynamic weight bearing as a novel end-point for the assessment of abdominal pain in the LPS-induced peritonitis model in the rat. ( Gruen, M; Laux-Biehlmann, A; Nagel, J; Zollner, TM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gruen, M | 1 |
| Laux-Biehlmann, A | 1 |
| Zollner, TM | 1 |
| Nagel, J | 1 |
1 other study available for rofecoxib and Peritonitis
| Article | Year |
|---|---|
Use of dynamic weight bearing as a novel end-point for the assessment of abdominal pain in the LPS-induced peritonitis model in the rat.
Topics: Abdominal Pain; Analysis of Variance; Animals; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease Mo | 2014 |